Growth Metrics

Incyte (INCY) EBITDA Margin (2016 - 2025)

Incyte (INCY) has disclosed EBITDA Margin for 16 consecutive years, with 22.29% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 329.0% year-over-year to 22.29%, compared with a TTM value of 29.46% through Dec 2025, up 2802.0%, and an annual FY2025 reading of 29.46%, up 2802.0% over the prior year.
  • EBITDA Margin was 22.29% for Q4 2025 at Incyte, down from 32.47% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 43.63% in Q2 2025 and bottomed at 45.81% in Q2 2024.
  • Average EBITDA Margin over 5 years is 16.62%, with a median of 18.98% recorded in 2023.
  • The sharpest move saw EBITDA Margin soared 13314bps in 2021, then plummeted -6611bps in 2024.
  • Year by year, EBITDA Margin stood at 12.83% in 2021, then tumbled by -41bps to 7.56% in 2022, then surged by 144bps to 18.48% in 2023, then skyrocketed by 38bps to 25.58% in 2024, then dropped by -13bps to 22.29% in 2025.
  • Business Quant data shows EBITDA Margin for INCY at 22.29% in Q4 2025, 32.47% in Q3 2025, and 43.63% in Q2 2025.